Newsroom | 35821 results

DUBLIN--(BUSINESS WIRE)--The "Medical Imaging Market" report has been added to ResearchAndMarkets.com's offering. The Medical Imaging Market was valued at USD 63.4 billion in 2024, and is projected to reach USD 82.6 billion by 2029, rising at a CAGR of 5.50%. Report Scope This research report comprehensively analyzes the medical imaging market, including forecasts and sales projections through 2029. The report provides an overview of product types, including X-ray systems, ultrasound devices, m...

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced today that it has achieved a critical milestone in its effort to reduce dependency on cold-storage for vaccines. In partnership with the nonprofit International AIDS Vaccine Initiative, Turn Therapeutics has validated a standardized assay and demonstrated 100% recovery of vesicular stomatitis virus (VSV) -- a widely used viral backbone in vaccine development -- after both 24 an...

RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech's Trio-Smart® 3-Gas Breath Test Featured at DDW 2025....

DUBLIN--(BUSINESS WIRE)--The "Masterclass: Market Authorisation of AI-enabled Medical Devices Training Course" conference has been added to ResearchAndMarkets.com's offering. Join this course to gain a solid understanding of the legislative landscape, enabling you to shape your use cases and secure a prosperous future for your AI initiatives. It is challenging to keep up with the rapidly changing regulations applicable to AI-based medical devices. Many AI providers face regulatory, implementati...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “2025 is off to a great start. The Butterfly team hit the mark...

サンディエゴ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 米国に本社を置き、JSRライフサイエンスおよび日本に本社を置くJSR株式会社傘下のグローバルCRO（開発業務受託機関）であるCrown Bioscienceは、世界最大級のフェーズIオンコロジー臨床試験ネットワークの一つであるNEXT Oncologyとの提携を延長することを発表いたします。この戦略的提携により、Crown Bioscienceの臨床的に意義のあるがんオルガノイドおよび患者由来異種移植（PDX）モデルの開発における豊富な経験と、NEXT Oncologyのグローバルな臨床ネットワークおよびフェーズI臨床試験の専門知識を、引き続き活用していくことになります。 この契約延長により、Crown Bioscienceは、NEXT Oncologyの業界をリードするグローバル臨床試験ネットワークから提供される患者サンプルに基づくサービスを提供する独占的権利を再確認します。この提携は、トランスレーショナル・オンコロジー研究において、臨床的に最も関連性の高いPDXおよびオルガノイドモデルとソリューションを提...

BOCA RATON, Fla.--(BUSINESS WIRE)--May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, is leveraging a wide range of activities to draw attention to the importance of prevention, early detection and treatment of the most common form of cancer that affects millions of people worldwide. Throughout...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will be hosting 1x1 meetings and participating in a fireside chat at the Citizens Life Sciences Conference on Thursday, May 8, 2025 at 10:30am EST/7:30am PST. The live webcast and subsequent replay will be available on the “Events & Presentations” section of the Company’s corporate webs...

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA...

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program...